KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Retained Earnings (2016 - 2025)

AbbVie (ABBV) has disclosed Retained Earnings for 14 consecutive years, with -$1.1 billion as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 40.57% to -$1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 billion through Dec 2025, up 40.57% year-over-year, with the annual reading at -$1.1 billion for FY2025, 40.57% up from the prior year.
  • Retained Earnings for Q4 2025 was -$1.1 billion at AbbVie, up from -$1.6 billion in the prior quarter.
  • The five-year high for Retained Earnings was $5.1 billion in Q1 2022, with the low at -$9.5 billion in Q1 2025.
  • Average Retained Earnings over 5 years is -$1.5 billion, with a median of -$2.3 billion recorded in 2023.
  • The sharpest move saw Retained Earnings plummeted 374.79% in 2021, then skyrocketed 265.02% in 2022.
  • Over 5 years, Retained Earnings stood at -$2.9 billion in 2021, then surged by 265.02% to $4.8 billion in 2022, then tumbled by 148.18% to -$2.3 billion in 2023, then grew by 16.49% to -$1.9 billion in 2024, then soared by 40.57% to -$1.1 billion in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$1.1 billion, -$1.6 billion, and -$1.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.